Support Centre
01 November 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

New application
Updating record

governing board
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Use of a web 2.0 portal to improve education and communication in young diabetes patients with families
DOI 10.1186/ISRCTN92107365
ClinicalTrials.gov identifier
EudraCT number
Public title Use of a web 2.0 portal to improve education and communication in young diabetes patients with families
Scientific title Use of a web 2.0 portal to improve education and communication in young diabetes patients with families: a randomised controlled trial
Acronym N/A
Serial number at source N/A
Study hypothesis A Web 2.0 portal, with diabetes-related information and the possibility to communicate with diabetes peers as well as with health care professionals, would
1. Be of complementary value in everyday life with diabetes, especially by newly diagnosed patients and patients in periods with instable metabolic control
2. Be perceived as helpful in self treatment; and
3. Contribute to improved metabolic control
Lay summary Lay summary under review 3
Ethics approval The study was approved by the Research Ethics Committee of the Faculty of Health Science at Linköping University, Sweden on 04/11/2003
Study design Randomised controlled study
Countries of recruitment Sweden
Disease/condition/study domain Type 1 Diabetes
Participants - inclusion criteria All the clinically diagnosed type 1 diabetes children registered in the Swedish paediatric diabetes quality registry, SWEDIABKIDS, belonging to the geographic population of the two paediatric clinics in Linköping and Jönköping, were eligible and invited to the study
Participants - exclusion criteria 1. No consent
2. Transferred to other clinic
Anticipated start date 11/04/2006
Anticipated end date 25/09/2008
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 474
Interventions The patients and their families were randomised (stratified for clinic) to either the intervention group or the control group.

At baseline April 2006, all subjects in the intervention group were offered a personal password to the portal for the first year of the study. After study year one, all subjects in the previous control group were also offered passwords to the portal. For children 13 years of age and older, both parents and adolescents received passwords while for younger children only parents received passwords. Basic information about the concept was given by posted letters, and informed consent to study participation was required before the first visit.
Primary outcome measure(s) 1. HbA1c
2. Number of severe hypoglycaemia incidents
Secondary outcome measure(s) 1. Health-Related Quality Of Life (HRQOL)
2. Empowerment and perception of quality of care regarding information
3. Hypoglycaemia (self-reported) and
4. Numbers of self-controls of blood glucose (self-reported)
5. User activity by site visits and page visits logged per user
Sources of funding 1. The Medical Research Council of Southeast Sweden (FORSS) (Sweden)
2. ALF Grants, County Council of Östergötland (Sweden)
3. The Swedish Child Diabetes Foundation (Barndiabetesfonden) (Sweden)
Trial website
Publications 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23973555
Contact name Dr  Sam  Nordfeldt
  Address Division of Child and Adolescent Psychiatry
Department of Clinical and Experimental Medicine
Linköping University
  City/town Linköping
  Zip/Postcode 581 85
  Country Sweden
  Email sam.nordfeldt@liu.se
Sponsor County Council of Östergötland (Landstinget i Ostergotland) (Sweden)
  Address Landstinget i Ostergotland
  City/town Linkoping
  Zip/Postcode 581 91
  Country Sweden
Date applied 25/11/2011
Last edited 27/08/2013
Date ISRCTN assigned 10/02/2012
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.